|
⚲
|
| Keyboard |
| Mark Udell | |
|---|---|
| Firm | |
| Address | 1620 Beacon Place Oxnard, CA 93033 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Cure Pharmaceutical Holding Corp | 021-340623 | Executive Officer | 19.0 M of 19.0 M |
||
| Cure Pharmaceutical Holding Corp | 021-309361 | Executive Officer | 1.0 M of 5.0 M |
||
| Cure Pharmaceutical Corp | 021-273536 | Executive Officer | 6.0 M of 6.0 M |
||
| Cure Pharmaceutical Corp | 021-273470 | Executive Officer | 0.2 M of 0.2 M |
||
| Cure Pharmaceutical Corp | 021-273501 | Executive Officer | 0.3 M of 0.3 M |
||
| Cure Pharmaceutical Corp | 021-273395 | Executive Officer | 2.0 M of 2.0 M |
||
| Cure Pharmaceutical Corp | 021-273396 | Executive Officer | 0.1 M of 0.1 M |
||
| Cure Pharmaceutical Corp | 021-181465 | Executive Officer | 1.0 M of 1.0 M |
||